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After the implantation of a cardiac implantable electronic
device, a rise in the capture threshold is a common
complication that requires early reintervention. Precise
measurements of the sensing amplitude and capture thresh-
old are important to estimate lead position and stability and
to determine sensing and pacing settings. Although pacing
rate is commonly thought not to signiﬁcantly affect capture
threshold, we encountered 3 patients undergoing pacemaker
implantation for sick sinus syndrome (SSS) in whom the
pacing rate was a critical determinant of successful capture of
the atrial myocardium because of a bradycardia-dependent
rise in the atrial capture threshold.
Case reports
Case 1
A 76-year-old woman was admitted to our hospital with
presyncope. Holter electrocardiography (ECG) showed sinus
pauses with a maximum R-R interval of 3.7 seconds
associated with the symptoms and paroxysms of atrial
ﬁbrillation. She received a dual-chamber pacemaker with a
passive ﬁxation atrial lead (CapSure Sense, Medtronic,
Minneapolis, MN) placed in the right atrial appendage.
The initial atrial capture threshold (0.5-V amplitude at 0.4-KEYWORDS Bradycardia; Pacemaker; Phase 4 block; Sick sinus syndrome;
Threshold
ABBREVIATIONS bpm ¼ beats per minute; ECG ¼ electrocardiography;
EPS ¼ electrophysiological study; SSS ¼ sick sinus syndrome
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).millisecond pulse width) was measured at the pacing rate of
90 beats per minute (bpm), 20 bpm higher than her baseline
heart rate. The sensing and impedance values were 1.4 mV
and 551 Ω, respectively. The initial pacemaker mode was
managed ventricular pacing (Medtronic) and 60 to 130 bpm.
The next day, patient monitoring showed atrial pacing spikes
without atrial depolarizations (P waves). Pacemaker inter-
rogation revealed a marked rise in the atrial capture thresh-
old, to 3.75 V at 0.4 milliseconds at 70 bpm. The sensing and
impedance values were slightly decreased, to 0.9 mV and
475 Ω, respectively. No measurement of the capture thresh-
old using different pacing rates was performed. Although
chest radiographs showed no apparent dislodgement of the
atrial lead, atrial lead replacement was performed with an
active ﬁxation lead (CapSureFix Novus, Medtronic). The
initial atrial capture threshold of this lead was 1.25 V at 0.4
milliseconds at 90 bpm. Monitoring on the following day
again showed failure of atrial pacing. This time, detailed
measurement of the atrial capture threshold was performed.
The threshold changed remarkably in accord with pacing
rate: 1.0 V at 0.4 milliseconds at 100 bpm, 1.5 V at 0.4
milliseconds at 80 bpm, and 43.5 V at 0.4 milliseconds
(noncapture) at 60 bpm. There was no signiﬁcant change in
the sensing or impedance value (1.4 mV and 475 Ω,
respectively). Therefore, the lower rate increased temporarily
to 75 bpm to avoid pacing failure.
Five days after implantation, a noninvasive electrophy-
siological study (EPS) was performed using the device’s
system. Programmed atrial stimulation at a basic cycle length
of 600 milliseconds was performed with the pacing output
ﬁxed at 4.0 V at 0.5 milliseconds (default setting of the
device’s EPS system). One atrial extrastimulus (S2) was
delivered after 15 paced atrial stimuli (S1). Because the
device system does not allow the S1-S2 interval to be4 600
milliseconds, the EPS protocol was as follows (Figure 1):pen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 A bradycardia-dependent rise in the atrial capture
threshold can occur in patients undergoing
implantation of cardiac implantable electronic
devices.
 Because this unfavorable phenomenon is expected
to resolve within a few months, reintervention for
lead revision may be avoidable.
 Electrocardiologists should measure the capture
threshold by pacing at higher rates if a rise in the
atrial capture threshold is observed early after
implantation.
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milliseconds:
First, the basic setting of pacemaker was set as atrial pacing,
atrial sensing, inhibited response (AAI) 30 bpm (2000
milliseconds). Next, 15 basic stimuli (S1-S1 interval, 600
milliseconds) were delivered using an EPS function. After
S1 stimuli were stopped, the next stimulus was delivered
2000 milliseconds later as a function of AAI 30 bpm. This
stimulus was substituted as the S2 stimulus. The basic
setting of the pacemaker was changed from AAI 30 bpm
(2000 milliseconds) to AAI 95 bpm (632 milliseconds) in
increments of 5 bpm. Because the reset rate in this system is
65 bpm (923 milliseconds), the S1-S2 interval of 65 bpm
cannot be assessed.
When the S1-S2 interval is r 600
milliseconds:
The S1-S2 interval was set from 600milliseconds until the atrial
effective refractory period in decrements of 10 milliseconds.
The results of the EPS were as follows (Figure 1):1. When the S1-S2 interval was 2000 milliseconds (30
bpm), a sinus beat appeared prior to S2.2. When the S1-S2 interval was 1714 milliseconds (35
bpm), S2 was captured with reproducibility.3. When the S1-S2 interval was from 1500 milliseconds (40
bpm) to 750 milliseconds (80 bpm), S2 was not captured.4. When the S1-S2 interval was from 706 milliseconds (85
bpm) to 260 milliseconds, S2 was captured.5. When the S1-S2 interval wasr 250 milliseconds, S2 was
not captured, and 260 milliseconds was the atrial effective
refractory period.
In summary, a unique bradycardia-dependent phenom-
enon with a noncapture range between 1500 milliseconds
and 750 milliseconds was observed shortly after device
implantation.
One month after implantation, the same EPS was
repeated. The S2 stimulus did not capture the atrium onlywhen the S1-S2 interval was 1000 milliseconds (60 bpm)
(Figure 2). The noncapture range had clearly decreased in 1
month. Two months later, the noncapture range had dis-
appeared, and the atrial capture threshold improved to 0.75 V
at 0.4 milliseconds at 60 bpm. The sensing and impedance
values were stable (1.4 mV and 361 Ω, respectively).
Case 2
A 74-year-old woman was hospitalized with presyncope due
to SSS. A Holter ECG showed long pauses with a maximum
R-R interval of 6.8 seconds. She received a dual-chamber
pacemaker with an active ﬁxation lead (Fineline II, Boston
Scientiﬁc, Marlborough, MA) placed in the upper atrial
septum. The initial atrial capture threshold was 0.8 V at 0.4
milliseconds at 80 bpm, 20 bpm higher than her baseline
heart rate. The sensing and impedance values were 2.3 mV
and 587 Ω, respectively. The initial pacemaker mode was
dual-chamber pacing, dual-chamber sensing, dual response
(DDD) and 60 to 110 bpm. Two days after implantation,
patient monitoring showed ventricular pacing after the fail-
ure of atrial pacing. Pacemaker interrogation revealed that
the atrial capture threshold was dependent on the pacing rate
as follows: 1.4 V at 0.4 milliseconds atZ70 bpm, 3.75 V at
0.4 milliseconds at 65 bpm, and 5 V at 0.4 milliseconds at 60
bpm. There were slight decreases in the sensing and
impedance values to 1.9 mV and 409 Ω, respectively.
Therefore, the lower rate rose to 70 bpm to avoid pacing
failure. One month after implantation, the atrial capture
threshold had improved to 0.6 V at 0.4 milliseconds atZ70
bpm, 1.0 V at 0.4 milliseconds at 65 bpm, and 1.7 V at 0.4
milliseconds at 60 bpm. Seven months after implantation the
atrial capture threshold had improved to 0.6 V at 0.4
milliseconds at all pacing rates. Although the sensing value
was unavailable because of the lack of her own atrial activity,
there was no change in the impedance value (429 Ω).
Case 3
An 86-year-old woman was hospitalized with syncope due to
SSS. A Holter ECG showed sinus arrest with junctional
escape beats at 30 bpm. She received a dual-chamber
pacemaker with an active ﬁxation lead (Fineline II, Boston
Scientiﬁc) placed in the right atrial appendage. The initial
atrial capture threshold was 0.6 V at 0.4 milliseconds at 60
bpm. The sensing and impedance values were 2.4 mV and
549 Ω, respectively. The pacemaker mode was DDD 60 to
130 bpm. One month after patient discharge, the ECG
showed ventricular pacing after the failure of atrial pacing.
Pacemaker interrogation revealed that the atrial capture
threshold had changed according to the pacing rate as
follows: 0.7 V at 0.4 milliseconds at 90 bpm, 1.1 V at 0.4
milliseconds at 80 bpm, and45 V at 0.4 milliseconds at 60
bpm. The sensing and impedance values were decreased to
0.7 mV and 493 Ω, respectively. Therefore, the lower rate
rose to 80 bpm to avoid pacing failure. At 1 year after
implantation, the atrial capture threshold had improved to 0.4
V at 0.4 milliseconds at 90 bpm, 0.6 V at 0.4 milliseconds at
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Figure 1 Programmed atrial stimulation was performed on the ﬁfth day after implantation. The basic stimuli (S1) cycle length was 600 milliseconds, and one
atrial extrastimulus (S2) was delivered 1714 milliseconds to 250 milliseconds after S1. When the S1-S2 interval was 1714 milliseconds (35 bpm), S2 was
captured with reproducibility. When the S1-S2 interval ranged from 1500 milliseconds (40 bpm) to 750 milliseconds (80 bpm), S2 did not capture the atrium.
When the S1-S2 interval ranged from 706 milliseconds (85 bpm) to 260 milliseconds, S2 captured the atrium. When the S1-S2 interval wasr 250 milliseconds,
S2 did not capture the atrium (atrial effective refractory period ¼ 260 milliseconds). The “noncapture range” lay between 1500 milliseconds and 750
milliseconds.
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signiﬁcant change in the sensing or impedance value (1.0
mV and 580 Ω, respectively).Discussion
The similarities in these 3 cases were that the patients were
elderly women with SSS but with no structural heart disease.In cases 1 and 2, the bradycardia-dependent rise in the atrial
capture threshold appeared within a few days after implan-
tation and had improved several months later. In case 3, the
manifestation of threshold rise was slower and remained
slight over 1 year.
The myocardial threshold to electrical stimulation (cap-
ture threshold) is sensitive to a variety of physiological,
pathologic, and pharmacologic changes. During the ﬁrst 24
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Figure 2 Programmed atrial stimulation was performed 1 month after implantation. The S2 stimulus failed to capture the atrium only when the S1-S2 interval
was 1000 milliseconds. The “noncapture range” was clearly reduced.
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appears to change very little. Over the next 7 to 10 days,
the threshold rises acutely as a result of injury, necrosis, and
subsequent ﬁbrosis of the myocardium at the point of
electrode contact. This early threshold increase after elec-
trode implantation apparently stabilizes by 3 months.1,2 To
the best of our knowledge, only 1 previous report has
referred to capture threshold changes dependent on pacing
rate. Katsumoto et al3 demonstrated rate-dependent threshold
changes, with lower thresholds at higher pacing rates (2.91
1.01 mA at 70 bpm vs. 2.32  0.75 mA at 120 bpm, P o
0.01). Because higher pacing rates reduce atrial end-diastolic
diameter, electrode contact with the endocardial surface
improves. Therefore, they suggested that ﬂuctuations in
electrode contact with the endocardium appeared responsiblefor such threshold changes. However, their report was
different from our cases in the degree of capture threshold
rise dependent on lower pacing rates (20% vs. 4300%). In
addition, the capture threshold was normalized again at a
remarkably low pacing rate (35 bpm) in case 1. Clearly,
different electrophysiological mechanisms contributed to the
phenomenon observed in our cases compared with those of
the prior report.
The bradycardia-dependent rise in the atrial capture
threshold observed in our cases may be explained by “phase
4 block.” Phase 4 block is responsible for atrioventricular
block, bundle branch block, and accessory pathway con-
duction block in some cases.4–6 Singer et al7 suggested that
phase 4 depolarization in potentially automatic cells could
explain the conduction abnormalities associated with
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Figure 3 Our assumption as to the membrane potentials of atrial
myocardium around the pacing lead according to the results from the
electrophysiological study of Case 1. A: The greater diastolic (phase 4)
depolarization caused by acute histologic changes creates a wide noncapture
range on the ﬁfth day after implantation. B: As diastolic depolarization
gradually improves, the noncapture range is reduced at 1 month after
implantation. C: Three months after implantation, the noncapture range has
disappeared.
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et al8 proposed that phase 4 block results from spontaneous
diastolic depolarization by reducing action potential ampli-
tude and upstroke velocity in an attempt to activate the
depolarized area.
Although the mechanism of the bradycardia-dependent
rise in the atrial capture threshold is unclear, it is possible that
pacemaker lead-induced inﬂammation, necrosis, and ﬁbrosis
of the atrial myocardium may cause spontaneous phase 4
depolarization. Our hypothesis is shown in detail in Figure 3.
Time-dependent recovery from such myocardial injury
(commonly within a few months) may account for the
transient nature of bradycardia-dependent threshold rise.
Moreover, atrial ﬁbrosis associated with SSS, female sex,
and aging that exists before the implantation may also
contribute to phase 4 depolarization.9
Nowadays, reintervention is needed in 2.8% to 4.4% of
patients who receive cardiac implantable electronic devi-
ces.10,11 About 20% of the reinterventions are due to lead
electrical malfunction, deﬁned as an abrupt change in leadimpedance, electrogram amplitude, or capture threshold.11
We estimate that cases of transient bradycardia-dependent
rise of atrial capture threshold might lead to reintervention.
However, early reintervention is associated with a410-fold
increase in the risk of device infection.12 From the present
cases, we recommend that electrocardiologists measure
capture threshold at higher rates if failure of atrial pacing
appears early after implantation. Also, if atrial pacing can
stabilize at a permissively high rate, it might be good to wait
a few months using this setting. Further investigations are
needed to clarify the precise mechanisms behind this
phenomenon.
Conclusion
Bradycardia-dependent rise in the atrial capture threshold
can occur in patients undergoing implantation of cardiac
implantable electronic devices. Because this phenomenon
can be easily recognized by pacing at a higher rate and is
usually transient early after implantation, it is important to
avoid unnecessary reintervention.
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